@EMPharmavich I should clarify as it was a little more involved. We also interviewed the patients, utilized an iVent for other pharmacists to follow-up, and posted a note in the chart with Poison Control official recs and ED pharmacist assessment. This was my PGY1 project!
🚨NEW POD ALERT🚨
2023 Year-In-Review Literature Review Series
Ft: Jac Crawford @JACuronium
Kate Hartman @HartKate8
First ever Year-In-Review episode! 🥇
8 different categories 8⃣
16 total articles 🎯
All voted on by YOU, the listeners 🗳️
🍎 https://t.co/qLoPzaBFMC
🟢 https://t.co/fiNCBWOnXn
🖥️ https://t.co/a0XrkwvgKU
🚨NEW POD ALERT🚨
RSI Part II 🫁
Ft. Christine Groth @GrothChristine
Angela Slapmak-Cindric @AngelaSlampak
Kevin Kaucher
PICO Partners 💕
2024 guideline scope 📝
Challenges with pharmacotherapy recs 🛑
MVP/Unsung hero 🏆
Practice-based research ideas 💡
& much more!
https://t.co/IfjmSKjyyj
https://t.co/UoGK2GRBnF
Meet Alyssa, our wonderful PGY2 Thrombosis and Hemostasis Management resident! Alyssa has done phenomenal work through her experience thus far, and she will be starting her ED rotation on Monday! #PharmRes#TwitteRx
🔥New @SCCM RSI Guidelines led by EM👑@nacquisto
✅Med-induced preoxygenation
❓Per-intubation pressors
✅Etomidate vs. other induction
❌Etomidate + steroids
✅Roc or succ
Amazing PharmD rep: @sidpatan@GrothChristine@AngelaSlampak & Kevin Kaucher
https://t.co/xNbVeqf9Kc
To the best year, the best residency program, and the best mentors, colleagues, & coresidents a girl could have hoped for. So happy it happened @TuftsMedicalCtr
What’s everyone’s go-to medication for agitation in the ED? We evaluated Ketamine vs Droperidol in our new paper. Full text link: https://t.co/xVW83MIviA
Today, FDA approved a naloxone hydrochloride nasal spray for over-the-counter, nonprescription, use – the first naloxone product approved for use without a prescription. https://t.co/KA9OSjDKiP
I am incredibly excited to have matched with @BrighamPharmacy to specialize in thrombosis and hemostasis management! Looking forward to the year ahead #twitterRx